A citation-based method for searching scientific literature

D F Stroup, J A Berlin, S C Morton, I Olkin, G D Williamson, D Rennie, D Moher, B J Becker, T A Sipe, S B Thacker. JAMA 2000
Times Cited: 13164







List of co-cited articles
96 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
25

Meta-analysis in clinical trials.
R DerSimonian, N Laird. Control Clin Trials 1986
21

Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
19

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
16


Quantifying heterogeneity in a meta-analysis.
Julian P T Higgins, Simon G Thompson. Stat Med 2002
11

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
Jonathan Ac Sterne, Miguel A Hernán, Barnaby C Reeves, Jelena Savović, Nancy D Berkman, Meera Viswanathan, David Henry, Douglas G Altman, Mohammed T Ansari, Isabelle Boutron,[...]. BMJ 2016
8

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. J Clin Epidemiol 2009
8


The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. PLoS Med 2009
6


Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
6

Estimating the mean and variance from the median, range, and the size of a sample.
Stela Pudar Hozo, Benjamin Djulbegovic, Iztok Hozo. BMC Med Res Methodol 2005
5

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
5

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
David Moher, Larissa Shamseer, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. Syst Rev 2015
4

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.
Jonathan A C Sterne, Alex J Sutton, John P A Ioannidis, Norma Terrin, David R Jones, Joseph Lau, James Carpenter, Gerta Rücker, Roger M Harbord, Christopher H Schmid,[...]. BMJ 2011
4

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
Beverley J Shea, Barnaby C Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson,[...]. BMJ 2017
4

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
4

Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software.
Nicola Orsini, Ruifeng Li, Alicja Wolk, Polyna Khudyakov, Donna Spiegelman. Am J Epidemiol 2012
782
4

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.
Penny F Whiting, Anne W S Rutjes, Marie E Westwood, Susan Mallett, Jonathan J Deeks, Johannes B Reitsma, Mariska M G Leeflang, Jonathan A C Sterne, Patrick M M Bossuyt. Ann Intern Med 2011
4

Interpretation of random effects meta-analyses.
Richard D Riley, Julian P T Higgins, Jonathan J Deeks. BMJ 2011
3

Publication bias in clinical research.
P J Easterbrook, J A Berlin, R Gopalan, D R Matthews. Lancet 1991
3

Assessing bias in studies of prognostic factors.
Jill A Hayden, Danielle A van der Windt, Jennifer L Cartwright, Pierre Côté, Claire Bombardier. Ann Intern Med 2013
3

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Ann Intern Med 2009
3

Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement.
Damian Hoy, Peter Brooks, Anthony Woolf, Fiona Blyth, Lyn March, Chris Bain, Peter Baker, Emma Smith, Rachelle Buchbinder. J Clin Epidemiol 2012
877
3

Methodological quality and synthesis of case series and case reports.
Mohammad Hassan Murad, Shahnaz Sultan, Samir Haffar, Fateh Bazerbachi. BMJ Evid Based Med 2018
547
3



Meta-analysis in clinical trials revisited.
Rebecca DerSimonian, Nan Laird. Contemp Clin Trials 2015
940
3

Rayyan-a web and mobile app for systematic reviews.
Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, Ahmed Elmagarmid. Syst Rev 2016
3

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. BMJ 2009
3

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
Larissa Shamseer, David Moher, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. BMJ 2015
3



The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. J Clin Epidemiol 2009
3

The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
Brian Hutton, Georgia Salanti, Deborah M Caldwell, Anna Chaimani, Christopher H Schmid, Chris Cameron, John P A Ioannidis, Sharon Straus, Kristian Thorlund, Jeroen P Jansen,[...]. Ann Intern Med 2015
3

The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence.
Zachary Munn, Sandeep Moola, Dagmara Riitano, Karolina Lisy. Int J Health Policy Manag 2014
397
2

Meta-analysis of prevalence.
Jan J Barendregt, Suhail A Doi, Yong Yi Lee, Rosana E Norman, Theo Vos. J Epidemiol Community Health 2013
789
2

Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.
Lesley A Stewart, Mike Clarke, Maroeska Rovers, Richard D Riley, Mark Simmonds, Gavin Stewart, Jayne F Tierney. JAMA 2015
792
2

Grading quality of evidence and strength of recommendations.
David Atkins, Dana Best, Peter A Briss, Martin Eccles, Yngve Falck-Ytter, Signe Flottorp, Gordon H Guyatt, Robin T Harbour, Margaret C Haugh, David Henry,[...]. BMJ 2004
2

The mutational constraint spectrum quantified from variation in 141,456 humans.
Konrad J Karczewski, Laurent C Francioli, Grace Tiao, Beryl B Cummings, Jessica Alföldi, Qingbo Wang, Ryan L Collins, Kristen M Laricchia, Andrea Ganna, Daniel P Birnbaum,[...]. Nature 2020
2

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
2

Metaprop: a Stata command to perform meta-analysis of binomial data.
Victoria N Nyaga, Marc Arbyn, Marc Aerts. Arch Public Health 2014
845
2


The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies.
Andra Morrison, Julie Polisena, Don Husereau, Kristen Moulton, Michelle Clark, Michelle Fiander, Monika Mierzwinski-Urban, Tammy Clifford, Brian Hutton, Danielle Rabb. Int J Technol Assess Health Care 2012
472
2


Dexamethasone in Hospitalized Patients with Covid-19.
Peter Horby, Wei Shen Lim, Jonathan R Emberson, Marion Mafham, Jennifer L Bell, Louise Linsell, Natalie Staplin, Christopher Brightling, Andrew Ustianowski, Einas Elmahi,[...]. N Engl J Med 2021
2

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Giacomo Grasselli, Alberto Zangrillo, Alberto Zanella, Massimo Antonelli, Luca Cabrini, Antonio Castelli, Danilo Cereda, Antonio Coluccello, Giuseppe Foti, Roberto Fumagalli,[...]. JAMA 2020
2

Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis.
Leiwen Fu, Bingyi Wang, Tanwei Yuan, Xiaoting Chen, Yunlong Ao, Thomas Fitzpatrick, Peiyang Li, Yiguo Zhou, Yi-Fan Lin, Qibin Duan,[...]. J Infect 2020
383
2

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
Xiaobo Yang, Yuan Yu, Jiqian Xu, Huaqing Shu, Jia'an Xia, Hong Liu, Yongran Wu, Lu Zhang, Zhui Yu, Minghao Fang,[...]. Lancet Respir Med 2020
2


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.